TOGA reduced in vitro HepG2 cell migration and invasion accelerated by co-cultured tumor-associated macrophages and mitigated IL-1β-induced HepG2 NF-κB activity, a key pathway associated with tumor progression. This evidence concerns the gene IL1B and neoplasm.